Skip to content

Clinical trials

Terminated Non-alcoholic Fatty Liver Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Terminated Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20101
20122
20151
20163
20173
20192
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
Celgene1
Enanta Pharmaceuticals, Inc1
Galectin Therapeutics Inc.1
Genfit1
GlaxoSmithKline1
Intercept Pharmaceuticals1
Johane Allard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease19
Fatty Liver3
Fibrosis3
Liver Cirrhosis3
Liver Diseases3
HIV Infections2
Acquired Immunodeficiency Syndrome1
Diabetes Mellitus, Type 21
Esophageal and Gastric Varices1
Hepatitis B1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.